Skip to main content

LadRx Corp

LADXDelisted
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000799698

LadRx Corp was delisted in 2025; its insiders filed their last Form 4 on Jan 29, 2024; no institution reported holding it in 13F filings for Q3 2025; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding LadRx Corp changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of LADX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders21−1
Shares25.9K14.3K−11.6K (−44.8%)
Value$2.00K$1.00K−$1.00K (−50.0%)

New holders (0)

Institutions that held LadRx Corp at the end of Q3 2022 but not at the end of Q2 2022.

None.

Sold out (1)

Institutions that held LadRx Corp at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of LADX in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Colonial Trust Advisors11,584$1.00K